Avidity Biosciences Appoints Sarah Boyce as Chief Executive Officer

LA JOLLA, Calif., Oct. 1, 2019 -- (Healthcare Sales & Marketing Network) -- Avidity Biosciences, a privately-held biotechnology company pioneering Antibody Oligonucleotide Conjugates (AOCs™), announced today the appointment of global business leader Sarah... Biopharmaceuticals, Personnel Avidity Biosciences, Antibody-Oligonucleotide Conjugates
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news